These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 15844233

  • 1. Experimental drug quickly suppresses HIV.
    AIDS Read; 2005 Apr; 15(4):150. PubMed ID: 15844233
    [No Abstract] [Full Text] [Related]

  • 2. Starving the virus.
    Res Initiat Treat Action; 1999 Apr; 5(2):32-3. PubMed ID: 11366283
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Emerging drugs in the fight against HIV disease.
    Rosenthal E.
    HRSA Careaction; 2003 Feb; ():1-8. PubMed ID: 12739497
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. T-1249 development hits a snag.
    AIDS Clin Care; 2004 Feb; 16(2):15. PubMed ID: 15032178
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Maraviroc--new HIV drug. Emerging options need to be used wisely.
    Vázquez E.
    Posit Aware; 2007 Feb; 18(4):18-9. PubMed ID: 17682275
    [No Abstract] [Full Text] [Related]

  • 12. FDA notifications. New antiretroviral guidelines issued.
    AIDS Alert; 2005 Jan; 20(1):11-2. PubMed ID: 15717358
    [No Abstract] [Full Text] [Related]

  • 13. FDA notifications. FDA approves raltegravir for HIV-1 treatment-naive patients.
    AIDS Alert; 2009 Sep; 24(9):106-7. PubMed ID: 19938313
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. I'm still the optimist.
    Burgess G.
    Surviv News (Atlanta Ga); 2001 Dec; ():17. PubMed ID: 11802621
    [No Abstract] [Full Text] [Related]

  • 16. Long path to approval. A look back at the road to Fuzeon.
    GMHC Treat Issues; 2003 Mar; 17(3):1-5. PubMed ID: 12728856
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A look ahead at this year's drug approvals.
    Proj Inf Perspect; 2007 Apr; (43):4-7. PubMed ID: 17684824
    [No Abstract] [Full Text] [Related]

  • 19. An overview of the drug approval process.
    Martinez LJ.
    Res Initiat Treat Action; 2002 Apr; 8(1):11-7. PubMed ID: 12489521
    [No Abstract] [Full Text] [Related]

  • 20. Is it time to rethink the expanded-access programs for HIV infection?
    Amorosa V, Tebas P.
    J Infect Dis; 2007 Oct 01; 196(7):974-7. PubMed ID: 17763316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.